Ultime notizie per Conagra Brands (NYSE:CAG) Azioni

CONAGRA BRANDS INC

Conagra Brands

Conagra Brands is a packaged food company that operates predominantly in the United States (over 90% of fiscal 2024 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. The company primarily sells through the US retail channel, with just 9% of fiscal 2024 revenue coming from international markets and 10% from foodservice.

News

Dividends

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

CALM

Valutazioni degli esperti su quali investimenti a dividendo offrono le migliori opportunità in tempi di incertezza.

Previsioni degli analisti: quali titoli a dividendo sono i migliori?

Scopri le tre migliori azioni ad alto rendimento consigliate dagli esperti di Wall Street per investimenti sicuri e redditizi.

3 azioni ad alto rendimento da prendere in considerazione

Conagra Brands Inc

SAMARA ASSET GROUP PLC by SAMARA ASSET GROUP PLC

Samara Asset Group PLC

CALIFORNIA GRAPES INTL by California Grapes International, Inc.

California Grapes International Inc

CASTLE GROUP INC UTAH by Castle Group, Inc. (THE)

Castle Group Inc

Morgan Stanley analyst Megan Alexander initiates coverage on Conagra Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) with a Equal-Weight rating and announces Price Target of $27.

Initiation

Morgan Stanley Initiates Coverage On Conagra Brands with Equal-Weight Rating, Announces Price Target of $27

<a href="https://www.reuters.com/business/retail-consumer/us-food-giants-pepsico-conagra-seek-exempt-some-imports-tariffs-trade-group-says-2025-03-12/" title="https://www.reuters.com/business/retail-consumer/us-food-giants-pepsico-conagra-seek-exempt-some-imports-tariffs-trade-group-says-2025-03-12/">https://www.reuters.com/business/retail-consumer/us-food-giants-pepsico-conagra-seek-exempt-some-imports-tariffs-trade-group-says-2025-03-12/</a>

Reuters Reported Wednesday, PepsiCo, Conagra, J M Smucker Requested President Trump Exempt Ingredients Not Available From U.S. Sources, From Tariffs

WIIM

COTY

Shares of consumer stocks are trading lower. Weak guidance from Kohl's may causing consumer spending concerns. Additional steel and aluminum tariffs may also increase input costs for some companies.

MDLZ

MNST

Shares of consumer staples stocks are trading higher. The sector may be up amid economic uncertainty and US tariffs, which could drive a rotation into defensive stocks.

Shares of consumer staples stocks are trading higher. Strength in the sector may be due to defensive rotation as investors assess tariff uncertainty and recent economic data.

JP Morgan analyst Ken Goldman maintains Conagra Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) with a Neutral and lowers the price target from $29 to $26.

JP Morgan Maintains Neutral on Conagra Brands, Lowers Price Target to $26

Conagra Brands's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) short percent of float has risen 5.15% since its last report. The company recently reported that it has 16.19 million shares sold short, which is 3.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Conagra Brands Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741181429_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Conagra Brands has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Conagra Brands's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Conagra Brands's peer group average for short interest as a percentage of float is 6.30%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

What's Driving the Market Sentiment Around Conagra Brands?

Goldman Sachs analyst Leah Jordan maintains Conagra Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) with a Neutral and lowers the price target from $33 to $26.

Goldman Sachs Maintains Neutral on Conagra Brands, Lowers Price Target to $26

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Mizuho cut Intra-Cellular Therapies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>) price target from $140 to $132. Mizuho analyst Graig Suvannavejh downgraded the stock from Outperform to Neutral. Intra-Cellular Therapies shares closed at $128.60 on Friday. <a href="https://www.benzinga.com/quote/ITCI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs slashed the price target for Conagra Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) from $33 to $26. Goldman Sachs analyst Leah Jordan downgraded the stock from Buy to Neutral. Conagra shares closed at $25.79 on Friday. <a href="https://www.benzinga.com/quote/CAG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities cut Rivian Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) price target from $13 to $10. B of A Securities analyst John Murphy downgraded the stock from Neutral to Underperform. Rivian Automotive, shares closed at $12.97 on Friday. <a href="https://www.benzinga.com/quote/RIVN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler cut the price target for Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) from $101 to $85. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating. Block shares closed at $68.35 on Friday. <a href="https://www.benzinga.com/quote/XYZ/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup slashed the price target for NICE Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NICE#NASDAQ">NICE</a>) from $279 to $228. Citigroup analyst Tyler Radke maintained a Buy rating. NICE shares closed at $155.39 on Friday. See how other <a href="https://www.benzinga.com/quote/NICE/analyst-ratings">analysts view this stock</a>.</li>
<li>RBC Capital cut Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) price target from $50 to $43. RBC Capital analyst Steven Shemesh maintained a Sector Perform rating. Wayfair shares settled at $41.83 on Friday. <a href="https://www.benzinga.com/quote/W/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital slashed Louisiana-Pacific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPX#NYSE">LPX</a>) price target from $117 to $110. Loop Capital analyst Jeffrey Stevenson maintained a Hold rating. Louisiana-Pacific shares closed at $98.71 on Friday. <a href="https://www.benzinga.com/quote/LPX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Scotiabank raised Nutrien Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTR#NYSE">NTR</a>) price target from $60 to $62. Scotiabank analyst Ben Isaacson maintained a Sector Outperform rating. Nutrien shares closed at $52.59 on Friday.  <a href="https://www.benzinga.com/quote/ntr/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies raised the price target for NIKE, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) from $75 to $115. Jefferies analyst Randal Konik upgraded the stock from Hold to Buy. Nike shares settled at $76.50 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel boosted Floor &amp; Decor Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FND#NYSE">FND</a>) price target from $100 to $110. Stifel analyst W. Andrew Carter upgraded the stock from Hold to Buy. Floor &amp; Decor shares closed at $94.27 on Friday. <a href="https://www.benzinga.com/quote/fnd/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43909524/top-3-tech-stocks-that-may-crash-in-q1">Top 3 Tech Stocks That May Crash In Q1</a></li>
</ul>

ITCI

NICE

RIVN

Nike To Rally Over 50%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Wells Fargo analyst Derek Archila downgraded the rating for Exelixis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) from Overweight to Equal-Weight and maintained the price target of $36. Exelixis shares closed at $36.85 on Friday. <a href="https://www.benzinga.com/quote/EXEL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst John Murphy downgraded Rivian Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) from Neutral to Underperform and lowered the price target from $13 to $10. Rivian Automotive shares closed at $12.97 on Friday. <a href="https://www.benzinga.com/quote/RIVN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Leah Jordan downgraded Conagra Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) from Buy to Neutral and lowered the price target from $33 to $26. Conagra Brands shares closed at $25.79 on Friday. <a href="https://www.benzinga.com/quote/CAG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Stephen Grambling downgraded Boyd Gaming Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) from Overweight to Equal-Weight and lowered the price target from $82 to $81. Boyd Gaming shares closed at $76.86 on Friday. <a href="https://www.benzinga.com/quote/BYD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho analyst Graig Suvannavejh downgraded the rating for Intra-Cellular Therapies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>) from Outperform to Neutral and slashed the price target from $140 to $132. Intra-Cellular Therapies shares closed at $128.60 on Friday. <a href="https://www.benzinga.com/quote/ITCI/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CAG stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="515" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24132029/image-195-1024x515.png" alt="" class="wp-image-796086" style="width:573px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24132029/image-195-1024x515.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24132029/image-195-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24132029/image-195-768x386.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24132029/image-195.png 1148w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43909524/top-3-tech-stocks-that-may-crash-in-q1">Top 3 Tech Stocks That May Crash In Q1</a></li>
</ul>

Downgrades

EXEL

This Conagra Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Goldman Sachs analyst Leah Jordan downgrades Conagra Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) from Buy to Neutral and lowers the price target from $33 to $26.

Goldman Sachs Downgrades Conagra Brands to Neutral, Lowers Price Target to $26

UBER

CNBC Halftime Report Final Trades: Uber Technologies, MP Materials, ConAgra Brands, UnitedHealth Group

Stifel analyst Matthew Smith maintains Conagra Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) with a Hold and lowers the price target from $28 to $26.

Stifel Maintains Hold on Conagra Brands, Lowers Price Target to $26

Wells Fargo analyst Chris Carey maintains Conagra Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) with a Equal-Weight and lowers the price target from $28 to $27.

Wells Fargo Maintains Equal-Weight on Conagra Brands, Lowers Price Target to $27

Conagra Brands shares are trading lower after the company lowered its FY25 adjusted EPS outlook.

Conagra Says In Q3, Experienced Manufacturing Challenges At Primary Facility That Prepares And Cooks Chicken Used In Frozen Meals

Updated Fiscal 2025 Outlook Reflects Temporary Service Constraints and Impact of Foreign Exchange; &nbsp;Long-Term Targets Unchanged
CHICAGO, Feb. 17, 2025 /PRNewswire/ -- Conagra Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) announced that its upcoming presentation at the annual Consumer Analyst Group of New York (CAGNY) Conference will detail Conagra's advantaged market position, perspective on the evolving consumer environment, and unique focus on the science of growth. Conagra will also preview a series of new innovations expected to launch in calendar year 2025 and provide detail on its updated fiscal 2025 financial guidance.&nbsp;
As previously announced, Sean Connolly, president and chief executive officer, Dave Marberger, executive vice president and chief financial officer, and Bob Nolan, senior vice president, growth science, will present on February 18 at 9:00 a.m. ET.
Fiscal 2025 Outlook Update The company has experienced customer service interruptions during the third quarter due to supply constraints on two product platforms: frozen meals containing chicken and frozen vegetables. In addition, foreign exchange rates are now expected to provide a further headwind to adjusted earnings per share.
As a result of these challenges, the company is making the following updates to its fiscal 2025 financial outlook1:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Metric</td>
<td colspan="1" rowspan="1">Prior Fiscal 2025 Guidance</td>
<td colspan="1" rowspan="1">Updated Fiscal 2025 Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Organic Net Sales Growth (vs. FY24)</td>
<td colspan="1" rowspan="1">Near the midpoint of (1.5)% to flat</td>
<td colspan="1" rowspan="1">~(2.0)%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted Operating Margin</td>
<td colspan="1" rowspan="1">~14.8%</td>
<td colspan="1" rowspan="1">~14.4%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EPS</td>
<td colspan="1" rowspan="1">$2.45 to $2.50</td>
<td colspan="1" rowspan="1">~$2.35</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Leverage Ratio</td>
<td colspan="1" rowspan="1">~3.4x</td>
<td colspan="1" rowspan="1">~3.55x</td>
</tr>
</tbody>
</table>
</figure>
The company's expectations for capital expenditures, free cash flow conversion, interest expense, Ardent Mills' contribution, pension income, adjusted effective tax rate and inflation remain unchanged from our second quarter earnings materials. The company's updated guidance does not include any potential impacts from new tariffs. Conagra's long-term financial targets are unchanged.

Guidance

Conagra Brands Updates FY25 Adj. EPS From $2.45-$2.50 To ~$2.35 Vs $2.46 Est.; Revenue From Near The Midpoint Of (1.5)% To Flat To ~(2.0)%

The rise of appetite-suppressing drugs like Ozempic is changing the way Americans eat, but there's a twist: <a href="https://www.benzinga.com/cannabis">cannabis</a> legalization is pulling consumer behavior in the opposite direction. Bloomberg's <a href="https://www.bloomberg.com/prognosis?sref=TBDibEcD">Prognosis newsletter</a> recently dug into this fascinating interplay, highlighting how these two trends are reshaping the food industry and public health.
<h3 class="wp-block-heading">The Ozempic Effect: Appetite On Pause</h3>
Ozempic, Wegovy and other GLP-1 agonists have become household names for their remarkable ability to help people shed pounds. These drugs don't just curb appetite, they're also influencing what people buy. According to a <a href="https://www.bloomberg.com/news/articles/2024-02-16/ozempic-users-cut-grocery-spending-by-up-to-9-survey-finds">Morgan Stanley report</a>, households using GLP-1 drugs have cut their spending on snacks, pastries and ice cream by 6% to 9%. Meanwhile, healthier options like yogurt and vegetable snacks are seeing a boost, as companies like Danone (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DANOY#OTC">DANOY</a>) and Nestlé adjust their product lines to meet demand.
Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>), maker of Ozempic, has even <a href="https://finance.yahoo.com/news/novo-nordisk-ceo-says-fielding-114820887.html">received calls</a> from food industry leaders worried about the drug's impact. And they have reason to be concerned: Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) has <a href="https://www.bloomberg.com/news/articles/2023-10-04/walmart-says-ozempic-weight-loss-drugs-causing-slight-pullback-by-shoppers">reported</a> that households with GLP-1 users are buying less food overall. As the popularity of these drugs grows, with the market <a href="https://www.jpmorgan.com/insights/global-research/current-events/obesity-drugs">projected</a> to hit $100 billion by 2030, the ripple effects are only just beginning.
<h3 class="wp-block-heading">Cannabis Legalization: The Munchies Are Big Business</h3>
On the flip side, marijuana legalization is sparking a very different trend. With recreational cannabis now legal in 24 states, the infamous &#8220;<a href="https://elplanteo.com/munchies/">munchies</a>&#8221; are giving a major boost to junk food sales. Researchers from the <a href="https://www.nber.org/papers/w33176">National Bureau of Economic Research</a> found that grocery spending on snacks, cookies and candy jumped nearly 9% in states that legalized recreational marijuana.
<h3 class="wp-block-heading">A Collision Of Cultural Forces</h3>
These two trends &#8211; Ozempic's appetite-suppressing revolution and cannabis' munchies-driven consumption &#8211; paint a complex picture of American eating habits. On one side, GLP-1 drugs are helping people slim down and rethink their diets. On the other, marijuana legalization is encouraging indulgence, particularly in the form of high-calorie comfort foods.
Companies are scrambling to adapt. Nestlé and Conagra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>), for instance, are launching new products designed to appeal to both GLP-1 users and cannabis consumers. Think high-protein, portion-controlled frozen meals that cater to health-conscious shoppers, alongside indulgent snacks that satisfy the munchies. It's a balancing act and a testament to the food industry's ability to pivot with the times.
<h3 class="wp-block-heading">The Bigger Picture: Health And Economics</h3>
Cannabis legalization has brought tangible economic benefits, including increased GDP, job creation and tax revenue for states where it's legal. For example, Colorado and California have reported billions in tax revenue since legalization. Moreover, cannabis policies have helped reduce arrests and shifted law enforcement resources toward other priorities, fostering a growing legal industry that has supported local economies.
At the same time, public health challenges remain. Research indicates mixed outcomes. While substance use and dependency have increased slightly in some states, other studies highlight a decrease in opioid-related deaths and alcohol consumption, suggesting cannabis can serve as a harm-reduction tool.
Meanwhile, GLP-1 drugs present their own set of challenges. While they offer a promising tool in combating obesity, their rapid adoption is forcing industries reliant on indulgent eating, from fast food to snacks, to rethink their strategies. Questions about the long-term effects of these drugs and their impact on consumer behavior remain unanswered.
<h3 class="wp-block-heading">What's Next?</h3>
The intersection of Ozempic's appetite suppression and cannabis's munchies effect highlights the complexity of consumer trends in the U.S. Will GLP-1 drugs lead to healthier lifestyles, or will the munchies win out? For now, it's clear that both trends are reshaping industries and pushing companies to innovate like never before.
Cover image made with Canva

Biotech

Cannabis

Health Care

DANOY

How Ozempic And Legal Weed Are Changing What America Eats

Stifel analyst Matthew Smith maintains Conagra Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) with a Hold and lowers the price target from $30 to $28.

Stifel Maintains Hold on Conagra Brands, Lowers Price Target to $28

Conagra Brands's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) short percent of float has risen 10.12% since its last report. The company recently reported that it has 15.95 million shares sold short, which is 3.81% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Conagra Brands Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736946923_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Conagra Brands has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Conagra Brands's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Conagra Brands's peer group average for short interest as a percentage of float is 5.59%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Comments

Conagra Brands

Notizie

Ultime notizie per Conagra Brands (NYSE:CAG) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO